What is it about?
The combined treatment of HeLa cells with cisplatin and digoxin has a synergistic cytotoxic and antiproliferative effect and these effects depend on the activation of the kinase Src.
Photo by Sarah Cervantes on Unsplash
Why is it important?
This study shows that combined treatment of digoxin and cisplatin is more effective to kill cervix cancer cells and how this happens.
Read the Original
This page is a summary of: Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability, Journal of Cellular Biochemistry, December 2017, Wiley, DOI: 10.1002/jcb.26499.
You can read the full text:
The following have contributed to this page